Can Novel Anticoagulants Reduce Thrombosis Without Increasing Bleeding – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Surasak Wichaiyo, published in Journal of Thrombosis and Haemostasis, adding:
“Pharmacology of anticoagulants: from heparin to novel target-specific agents.
This review delineates the pharmacology of currently available anticoagulants (heparins, warfarin, and direct oral anticoagulants) alongside investigational agents.
Factor XI and factor XII inhibitors emerge as targets that may uncouple antithrombotic efficacy from bleeding risk, with several FXI inhibitors now in phase II and III trials.”
Title: Pharmacology of anticoagulants: from heparin to novel target-specific agents
Authors: Surasak Wichaiyo
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 29, 2026, 23:09Brad Flora: Reaching 15 Gallons of Lifetime Blood Donations
-
Oct 29, 2026, 23:07David McIntosh: Why We Need Thousands of Blood Donations Every Day
-
Oct 29, 2026, 23:07Tamer El-Sayed: Could Anaemia Be an Overlooked Factor in Patients with Intermittent Claudication?
-
Oct 29, 2026, 23:05Sakditad Saowapa: AF and Cancer From Shared Biology to Anticoagulation Challenges
-
Oct 29, 2026, 23:03Sabina Ali: The SToP Curriculum for Venous Thromboembolism Prevention in Pediatric IBD
-
Oct 29, 2026, 21:50Dave Cartland: Comparing Cerebral Thromboembolism Reports After COVID-19 and Influenza Vaccination
-
Oct 29, 2026, 16:39A Scholarship Creating Opportunities for Women with Bleeding Disorders – WFH
-
Oct 29, 2026, 16:30Wendy Disbro: AABB Highlights the People and Experience Behind Transfusion Medicine
-
Oct 29, 2026, 16:23Reza Shojaei: Artificial Intelligence in Blood Donation